C Palmason
Overview
Explore the profile of C Palmason including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
199
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wolever T, Chiasson J, Josse R, Hunt J, Palmason C, Rodger N, et al.
Diabetes Care
. 1998 Oct;
21(10):1612-8.
PMID: 9773719
Objective: To determine the relationship between carbohydrate intake and the effect of acarbose on HbA1c in subjects with type 2 diabetes treated with acarbose alone, acarbose plus sulfonylurea, acarbose plus...
2.
Wolever T, Chiasson J, Csima A, Hunt J, Palmason C, Ross S, et al.
Diabetes Care
. 1998 Apr;
21(3):336-40.
PMID: 9540012
Objective: To compare within-subject variability of plasma glucose measured 2 h after a glucose tolerance test (GTT) with that of plasma glucose measured 2 h after administration of a standardized...
3.
Wolever T, Chiasson J, Josse R, Hunt J, Palmason C, Rodger N, et al.
Int J Obes Relat Metab Disord
. 1997 Nov;
21(9):756-63.
PMID: 9376887
Objectives: To see if the long-term treatment of non-insulin dependent diabetes (NIDDM) with the alpha-glucosidase inhibitor acarbose affects food intake and body weight. Design: Randomized, double-blind, placebo-controlled, parallel design clinical...
4.
Chiasson J, Josse R, Leiter L, Mihic M, Nathan D, Palmason C, et al.
Diabetes Care
. 1996 Nov;
19(11):1190-3.
PMID: 8908378
Objective: To study the effect of acarbose, an alpha-glucosidase inhibitor, on postprandial plasma glucose and insulin and insulin sensitivity in subjects with impaired glucose tolerance (IGT). Research Design And Methods:...
5.
Rodger N, Chiasson J, Josse R, Hunt J, Palmason C, Ross S, et al.
Clin Invest Med
. 1995 Aug;
18(4):318-24.
PMID: 8549019
Current therapeutic options for the treatment of non-insulin-dependent diabetes mellitus (NIDDM) focus on regimens that primarily lower fasting blood glucose concentrations. In several short-term studies, the alpha-glucosidase inhibitor, acarbose, has...
6.
Wolever T, Radmard R, Chiasson J, Hunt J, Josse R, Palmason C, et al.
Diabet Med
. 1995 Feb;
12(2):164-72.
PMID: 7743764
alpha-Glucosidase inhibitors such as acarbose improve blood glucose control in diabetes by delaying or reducing carbohydrate absorption. The fermentation of malabsorbed carbohydrate in the colon is associated with the production...
7.
Hegele R, Connelly P, Palmason C, Jenkins D, Wolever T
Diabetes Care
. 1995 Feb;
18(2):272-3.
PMID: 7729310
No abstract available.
8.
Chiasson J, Josse R, Hunt J, Palmason C, Rodger N, Ross S, et al.
Ann Intern Med
. 1994 Dec;
121(12):928-35.
PMID: 7734015
Objective: To evaluate the long-term efficacy of acarbose, an alpha-glucosidase inhibitor, in improving glycemic control in patients with non-insulin-dependent diabetes mellitus. Design: A 1-year, multicenter, randomized, double-blind, placebo-controlled study. Setting:...
9.
Wolever T, Nguyen P, Chiasson J, Hunt J, Josse R, Palmason C, et al.
Am J Clin Nutr
. 1994 Jun;
59(6):1265-9.
PMID: 8198048
Controlled trials have shown that a diet with a low glycemic index improves blood glucose and lipid control in patients with diabetes. To study the distribution and determinants of diet...
10.
Hewitt L, Palmason C, Masson S, Plaa G
Liver
. 1990 Feb;
10(1):35-48.
PMID: 2308479
Ketones can potentiate the hepatotoxicity of haloalkanes in animals. This may be due, in part, to changes in organelle susceptibility. Male Sprague-Dawley rats were administered 15 mmol/kg (po) acetone, 2-butanone,...